Gero is a biotechnology company that provides therapeutics against chronic diseases
Gero has raised $17.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2026.
Gero's investors include VitaDAO, Bulba Ventures, Melnichek Investments, Leo Lozner.
Gero is headquartered in Singapore, Singapore.
Gero is a biotechnology company that provides therapeutics against chronic diseases
Gero is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Gero — Funding & Investors." VCBacked, June 17, 2026, https://www.vcbacked.co/company/gero. Accessed September 30, 2026.
VCBacked. (2026). Gero — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/gero
{{cite web |title=Gero — Funding & Investors |url=https://www.vcbacked.co/company/gero |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated